Inspired by these considerations, AKT1 was investigated as a further target in addition to ARHGAP29 for expression analyses to compare breast cancer cells with reduced and normal ARHGAP29 expression and to investigate a possible signal cascade around ARHGAP29. Here, AKT1 is linked to breast carcinoma.